Skip to content
10-Q

Quarterly Report

Akebia Therapeutics, Inc. AKBA

0001517022-25-000046

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 265.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 274.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 262.68M sh
Shares Diluted Q3 2025 · Sep 30, 2024 210.35M sh
Shares Diluted Q3 2025 · Sep 30, 2024 208.34M sh
Capex Q3 2025 · Sep 30, 2025 $221K
Capex Q3 2025 · Sep 30, 2024 $31K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $36.86M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$36.19M
Long Term Debt Q3 2025 · Sep 30, 2025 $47.64M
Long Term Debt Q3 2025 · Dec 31, 2024 $38.69M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $166.44M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $51.87M
Stockholders Equity Q3 2025 · Sep 30, 2025 $41.59M
Stockholders Equity Q3 2025 · Jun 30, 2025 $29.22M
Stockholders Equity Q3 2025 · Mar 31, 2025 $24.58M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$49.19M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$50.4M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$33.75M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$27.26M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$30.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $133.38M
Current Liabilities Q3 2025 · Dec 31, 2024 $80.91M
Total Liabilities Q3 2025 · Sep 30, 2025 $322.56M
Total Liabilities Q3 2025 · Dec 31, 2024 $269.86M
Current Assets Q3 2025 · Sep 30, 2025 $258.34M
Current Assets Q3 2025 · Dec 31, 2024 $113.83M
Total Assets Q3 2025 · Sep 30, 2025 $364.15M
Total Assets Q3 2025 · Dec 31, 2024 $220.67M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 $0.03
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 $0.03
Eps Basic Q3 2025 · Sep 30, 2024 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Sga Expense Q3 2025 · Sep 30, 2025 $29.09M
Sga Expense Q3 2025 · Sep 30, 2025 $81.39M
Sga Expense Q3 2025 · Sep 30, 2024 $26.52M
Sga Expense Q3 2025 · Sep 30, 2024 $78.87M
Rd Expense Q3 2025 · Sep 30, 2025 $14.94M
Rd Expense Q3 2025 · Sep 30, 2025 $35.71M
Rd Expense Q3 2025 · Sep 30, 2024 $8.49M
Rd Expense Q3 2025 · Sep 30, 2024 $25.87M
Net Income Q3 2025 · Sep 30, 2025 $540K
Net Income Q3 2025 · Sep 30, 2025 $6.9M
Net Income Q3 2025 · Jun 30, 2025 $247K
Net Income Q3 2025 · Mar 31, 2025 $6.11M
Net Income Q3 2025 · Sep 30, 2024 −$20.04M
Net Income Q3 2025 · Sep 30, 2024 −$46.61M
Net Income Q3 2025 · Jun 30, 2024 −$8.58M
Net Income Q3 2025 · Mar 31, 2024 −$17.99M
Operating Income Q3 2025 · Sep 30, 2025 $4.45M
Operating Income Q3 2025 · Sep 30, 2025 $32.05M
Operating Income Q3 2025 · Sep 30, 2024 −$12.51M
Operating Income Q3 2025 · Sep 30, 2024 −$36.17M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $9.38M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $26.93M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $14.16M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $42.81M
Revenue Q3 2025 · Sep 30, 2025 $58.77M
Revenue Q3 2025 · Sep 30, 2025 $178.57M
Revenue Q3 2025 · Sep 30, 2024 $37.43M
Revenue Q3 2025 · Sep 30, 2024 $113.68M